Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


12.06.2017

1 BMJ
1 Br J Psychiatry
1 Can J Psychiatry
1 J Clin Psychiatry
7 J Clin Psychopharmacol
1 J Nerv Ment Dis
1 Neuropsychopharmacology
1 PLoS Genet
2 PLoS One
5 Psychiatry Res
1 Psychol Med
12 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. MAYOR S
    Antipsychotics vary in preventing treatment relapse in schizophrenia, study finds.
    BMJ. 2017;357:j2788.
    PubMed     Text format    


    Br J Psychiatry

  2. ZHUO C, Tao R, Jiang R, Lin X, et al
    Cancer mortality in patients with schizophrenia: systematic review and meta-analysis.
    Br J Psychiatry. 2017 Jun 8. pii: bjp.bp.116.195776.
    PubMed     Text format     Abstract available


    Can J Psychiatry

  3. MUNOZ-NEGRO JE, Ibanez-Casas I, de Portugal E, Lozano-Gutierrez V, et al
    A Psychopathological Comparison between Delusional Disorder and Schizophrenia.
    Can J Psychiatry. 2017 Jan 1:706743717706347. doi: 10.1177/0706743717706347.
    PubMed     Text format     Abstract available


    J Clin Psychiatry

  4. TAKEUCHI H, Lee J, Fervaha G, Foussias G, et al
    Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
    J Clin Psychiatry. 2017;78:223-228.
    PubMed     Text format     Abstract available


    J Clin Psychopharmacol

  5. GOTO T, Kato M, Matsumura Y, Omata N, et al
    Scopolamine Ointment for Clozapine-Associated Sialorrhea: A Case Report.
    J Clin Psychopharmacol. 2017;37:106-107.
    PubMed     Text format    

  6. LOOK ML, Boo YL, Chin PW, Hoo FK, et al
    Risperidone-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome: A Case Report.
    J Clin Psychopharmacol. 2017;37:105-106.
    PubMed     Text format    

  7. BUCHANAN RW, Kelly DL, Weiner E, Gold JM, et al
    A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000720.
    PubMed     Text format     Abstract available

  8. KANTROWITZ JT, Nolan KA, Epstein ML, Lehrfeld N, et al
    Neurophysiological Effects of Bitopertin in Schizophrenia.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000722.
    PubMed     Text format     Abstract available

  9. WATANABE J, Fukui N, Suzuki Y, Sugai T, et al
    Effect of GWAS-Identified Genetic Variants on Maximum QT Interval in Patients With Schizophrenia Receiving Antipsychotic Agents: A 24-Hour Holter ECG Study.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000724.
    PubMed     Text format     Abstract available

  10. BARMAN R, Kumar S, Pagadala B, Detweiler MB, et al
    Cocaine Abuse, Traumatic Brain Injury, and Preexisting Brain Lesions as Risk Factors for Bupropion-Associated Psychosis.
    J Clin Psychopharmacol. 2017 Jun 5. doi: 10.1097/JCP.0000000000000729.
    PubMed     Text format     Abstract available

  11. BRUNO A, Pandolfo G, Crucitti M, Cedro C, et al
    Bergamot Polyphenolic Fraction Supplementation Improves Cognitive Functioning in Schizophrenia: Data From an 8-Week, Open-Label Pilot Study.
    J Clin Psychopharmacol. 2017 Jun 6. doi: 10.1097/JCP.0000000000000730.
    PubMed     Text format     Abstract available


    J Nerv Ment Dis

  12. FARAVELLI C, Mansueto G, Palmieri S, Lo Sauro C, et al
    Childhood Adversity, Cortisol Levels, and Psychosis: A Retrospective Investigation.
    J Nerv Ment Dis. 2017 Jun 8. doi: 10.1097/NMD.0000000000000699.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  13. DOYLE GA, Crist RC, Karatas ET, Hammond MJ, et al
    Analysis of LINE-1 Elements in DNA from Postmortem Brains of Individuals with Schizophrenia.
    Neuropsychopharmacology. 2017 Jun 6. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    PLoS Genet

  14. POLIMANTI R, Gelernter J
    Widespread signatures of positive selection in common risk alleles associated to autism spectrum disorder.
    PLoS Genet. 2017;13:e1006618.
    PubMed     Text format     Abstract available


    PLoS One

  15. RANDALL J, Chateau D, Bolton JM, Smith M, et al
    Increasing medication adherence and income assistance access for first-episode psychosis patients.
    PLoS One. 2017;12:e0179089.
    PubMed     Text format     Abstract available

  16. CONTRERAS F, Albacete A, Tebe C, Benejam B, et al
    Patients with schizophrenia activate behavioural intentions facilitated by counterfactual reasoning.
    PLoS One. 2017;12:e0178860.
    PubMed     Text format     Abstract available


    Psychiatry Res

  17. PRISTED SG, Correll CU, Nielsen J
    Frequency and correlates of anticholinergic use among patients with schizophrenia in Denmark: A Nation-wide pharmacoepidemiological study.
    Psychiatry Res. 2017;255:198-203.
    PubMed     Text format     Abstract available

  18. GABRIEL D, Jakubovski E, Taylor JH, Artukoglu BB, et al
    Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study.
    Psychiatry Res. 2017;255:248-255.
    PubMed     Text format     Abstract available

  19. LI J, Guo YB, Huang YG, Liu JW, et al
    Stigma and discrimination experienced by people with schizophrenia living in the community in Guangzhou, China.
    Psychiatry Res. 2017;255:225-231.
    PubMed     Text format     Abstract available

  20. TIMUCIN OB, Mutlu EA, Timucin D, Aslanci ME, et al
    Psychophysical assessment of koniocellular pathway in patients with schizophrenia versus healthy controls.
    Psychiatry Res. 2017;266:27-34.
    PubMed     Text format     Abstract available

  21. BJORNESTAD J, Hegelstad WTV, Joa I, Davidson L, et al
    "With a little help from my friends" social predictors of clinical recovery in first-episode psychosis.
    Psychiatry Res. 2017;255:209-214.
    PubMed     Text format     Abstract available


    Psychol Med

  22. BORA E, Ozerdem A
    Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia.
    Psychol Med. 2017 Jun 6:1-14. doi: 10.1017/S0033291717001490.
    PubMed     Text format     Abstract available


    Schizophr Res

  23. SEARLES S, Makarewicz JA, Dumas JA
    The role of estradiol in schizophrenia diagnosis and symptoms in postmenopausal women.
    Schizophr Res. 2017 Jun 3. pii: S0920-9964(17)30299.
    PubMed     Text format     Abstract available

  24. VYAS NS, Buchsbaum MS, Lehrer DS, Merrill BM, et al
    D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naive patients with schizophrenia.
    Schizophr Res. 2017 May 30. pii: S0920-9964(17)30276.
    PubMed     Text format     Abstract available

  25. NEUHAUS AH, Popescu FC
    Impact of sample size and matching on single-subject classification of schizophrenia: A meta-analysis.
    Schizophr Res. 2017 May 30. pii: S0920-9964(17)30300.
    PubMed     Text format    

  26. SCHALINSKI I, Teicher MH, Carolus AM, Rockstroh B, et al
    Defining the impact of childhood adversities on cognitive deficits in psychosis: An exploratory analysis.
    Schizophr Res. 2017 May 30. pii: S0920-9964(17)30273.
    PubMed     Text format     Abstract available

  27. HASTRUP LH, Haahr UH, Jansen JE, Simonsen E, et al
    Determinants of duration of untreated psychosis among first-episode psychosis patients in Denmark: A nationwide register-based study.
    Schizophr Res. 2017 May 31. pii: S0920-9964(17)30301.
    PubMed     Text format     Abstract available

  28. HORAT SK, Favre G, Prevot A, Ventura J, et al
    Impaired social cognition in schizophrenia during the Ultimatum Game: An EEG study.
    Schizophr Res. 2017 Jun 1. pii: S0920-9964(17)30311.
    PubMed     Text format     Abstract available

  29. LLERENA K, Reddy LF, Kern RS
    The role of experiential and expressive negative symptoms on job obtainment and work outcome in individuals with schizophrenia.
    Schizophr Res. 2017 Jun 6. pii: S0920-9964(17)30329.
    PubMed     Text format     Abstract available

  30. KAMP D, Engelke C, Wobrock T, Kunze B, et al
    Letter to the Editor: Influence of rTMS on smoking in patients with schizophrenia.
    Schizophr Res. 2017 Jun 1. pii: S0920-9964(17)30312.
    PubMed     Text format    

  31. BEASLEY CL, Honer WG, Ramos-Miguel A, Vila-Rodriguez F, et al
    Prefrontal fatty acid composition in schizophrenia and bipolar disorder: Association with reelin expression.
    Schizophr Res. 2017 Jun 2. pii: S0920-9964(17)30309.
    PubMed     Text format     Abstract available

  32. WANG S, Zhang Y, Lv L, Wu R, et al
    Abnormal regional homogeneity as a potential imaging biomarker for adolescent-onset schizophrenia: A resting-state fMRI study and support vector machine analysis.
    Schizophr Res. 2017 Jun 3. pii: S0920-9964(17)30315.
    PubMed     Text format     Abstract available

  33. DEAN DJ, Samson AT, Newberry R, Mittal VA, et al
    Motion energy analysis reveals altered body movement in youth at risk for psychosis.
    Schizophr Res. 2017 Jun 3. pii: S0920-9964(17)30310.
    PubMed     Text format     Abstract available

  34. TAKAHASHI H, Kamio Y
    Acoustic startle response and its modulation in schizophrenia and autism spectrum disorder in Asian subjects.
    Schizophr Res. 2017 Jun 1. pii: S0920-9964(17)30308.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: